Benjamin S Teeter1, Cynthia Mosley2, Jeremy L Thomas2, Bradley Martin3, Duane Jones4, Jose R Romero5, Geoffrey M Curran2. 1. Center for Implementation Research, Department of Pharmacy Practice, University of Arkansas for Medical Sciences, Little Rock, AR, USA. Electronic address: bsteeter@uams.edu. 2. Center for Implementation Research, Department of Pharmacy Practice, University of Arkansas for Medical Sciences, Little Rock, AR, USA. 3. Pharmaceutical Evaluation and Policy, Department of Pharmacy Practice, University of Arkansas for Medical Sciences, Little Rock, AR, USA. 4. Harps Food Stores, Inc., Springdale, AR, USA. 5. Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Abstract
BACKGROUND: Nearly 80 million people in the United States have contracted the Human Papillomavirus (HPV), and it is currently the most common sexually transmitted disease. Each year approximately 14 million people are newly infected. OBJECTIVE(S): This study will address increasing the HPV vaccination rates by initiating a research agenda focusing on how best to utilize community pharmacies as Vaccines For Children (VFC) vaccination sites. Community pharmacies are highly accessible when compared to traditional vaccination sites due to extended evening and weekend business hours, no copays for visits, and no appointment required to speak with a pharmacist. METHODS: We will conduct a Developmental Formative Evaluation using semi-structured interviews with key informants (pharmacists, pharmacy managers, technicians) from 5 Harps pharmacies to identify barriers and facilitators to community pharmacies' provision of HPV vaccine through a mixed methods design with pharmacy staff members and local physicians. We will follow that by selecting a pharmacist-physician collaborative model and identify implementation strategies through an Evidence Based Quality Improvement (EBQI) process with key stakeholders. This will be followed by piloting the selected pharmacist-physician collaborative model and implementation strategies in two Harps pharmacies (1 rural, 1 urban) on relevant implementation outcomes. PROJECT IMPACT: This study will examine the current model of HPV vaccinations and how to improve HPV vaccination rates among adolescents by utilizing community pharmacy services.
BACKGROUND: Nearly 80 million people in the United States have contracted the Human Papillomavirus (HPV), and it is currently the most common sexually transmitted disease. Each year approximately 14 million people are newly infected. OBJECTIVE(S): This study will address increasing the HPV vaccination rates by initiating a research agenda focusing on how best to utilize community pharmacies as Vaccines For Children (VFC) vaccination sites. Community pharmacies are highly accessible when compared to traditional vaccination sites due to extended evening and weekend business hours, no copays for visits, and no appointment required to speak with a pharmacist. METHODS: We will conduct a Developmental Formative Evaluation using semi-structured interviews with key informants (pharmacists, pharmacy managers, technicians) from 5 Harps pharmacies to identify barriers and facilitators to community pharmacies' provision of HPV vaccine through a mixed methods design with pharmacy staff members and local physicians. We will follow that by selecting a pharmacist-physician collaborative model and identify implementation strategies through an Evidence Based Quality Improvement (EBQI) process with key stakeholders. This will be followed by piloting the selected pharmacist-physician collaborative model and implementation strategies in two Harps pharmacies (1 rural, 1 urban) on relevant implementation outcomes. PROJECT IMPACT: This study will examine the current model of HPV vaccinations and how to improve HPV vaccination rates among adolescents by utilizing community pharmacy services.
Authors: Hildi Hagedorn; Mary Hogan; Jeffrey L Smith; Candice Bowman; Geoffrey M Curran; Donna Espadas; Barbara Kimmel; Laura Kochevar; Marcia W Legro; Anne E Sales Journal: J Gen Intern Med Date: 2006-02 Impact factor: 5.128
Authors: Alexander G Fiks; Robert W Grundmeier; Stephanie Mayne; Lihai Song; Kristen Feemster; Dean Karavite; Cayce C Hughes; James Massey; Ron Keren; Louis M Bell; Richard Wasserman; A Russell Localio Journal: Pediatrics Date: 2013-05-06 Impact factor: 7.124
Authors: Parth D Shah; William A Calo; Macary W Marciniak; Melissa B Gilkey; Noel T Brewer Journal: Cancer Epidemiol Biomarkers Prev Date: 2018-06-05 Impact factor: 4.254
Authors: Junling Wang; Lindsay J Ford; La'Marcus Wingate; Sarah Frank Uroza; Nina Jaber; Cindy T Smith; Richard Randolph; Steve Lane; Stephan L Foster Journal: J Am Pharm Assoc (2003) Date: 2013 Jan-Feb
Authors: Geoffrey M Curran; Greer Sullivan; Peter Mendel; Michelle G Craske; Cathy D Sherbourne; Murray B Stein; Ashley McDaniel; Peter Roy-Byrne Journal: Implement Sci Date: 2012-03-09 Impact factor: 7.327
Authors: Salisa C Westrick; Lindsey A Hohmann; Stuart J McFarland; Benjamin S Teeter; Kara K White; Tessa J Hastings Journal: Papillomavirus Res Date: 2016-12-21